Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, 36805-36806 [2017-16608]

Download as PDF Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Commission on Childhood Vaccines Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with section 10(a)(2) of the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following Web site: http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html. DATES: The meeting will be held on September 8, 2017, at 10:00 a.m. EDT. ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, MD, Conference Room 5N54. The public can join the meeting by: 1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, Division of Injury Compensation Programs (DICP), Healthcare Systems Bureau (HSB), HRSA, Rm. 8N146B, 5600 Fishers Lane, Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. This written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Amber Johnson at (301) 443–0129. 2. (Audio Portion) Call the conference phone number (800) 369–1833 and providing the following information: Leader Name: Dr. Narayan Nair Password: 6706374 3. (Visual Portion) Connect to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/. Participants should call and connect 15 minutes prior to the meeting to allow mstockstill on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 time for the logistics to be set-up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https:// hrsa.connectsolutions.com/common/ help/en/support/meeting_test.htm. Get a quick overview of the software at: http://www.adobe.com/go/ connectpro_overview. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, HRSA in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 8N146B, Rockville, Maryland 20857; (2) call (301) 443– 6593; or (3) send an email to aherzog@ hrsa.gov. The ACCV will meet on Friday, September 8, 2017, beginning at 10:00 a.m. in the 5600 Fishers Lane Building, Rockville, Maryland 20857; however, meeting times and locations could change. For the latest information regarding meeting start time and location, please check the ACCV Web site: http://www.hrsa.gov/advisory committees/childhoodvaccines/ index.html. The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa–19), as enacted by Public Law (Pub. L.) 99–660, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). Activities of the ACCV also include: Recommending changes to the Vaccine Injury Table on its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and recommending to the Director of the National Vaccine Program research related to vaccine SUPPLEMENTARY INFORMATION: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 36805 injuries which should be conducted to carry out the VICP. The agenda items for the meeting will include, but are not limited to, updates from DICP, Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html) prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog using the address and phone number above by September 4, 2017. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–16582 Filed 8–4–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The U.S. Department of Health and Human Services (HHS) announces the next meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee). The meeting is open to the public and will be held in the Washington, DC metropolitan area. The Committee is working to accomplish its mission to provide independent advice based on current scientific evidence for SUMMARY: E:\FR\FM\07AUN1.SGM 07AUN1 36806 Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices use by the Secretary of the U.S. Department of Health and Human Services or a designated representative in the development of Healthy People 2030. The Committee will meet on September 6, 2017, from 8:30 a.m. to 5:00 p.m. Eastern Time (ET), and September 7, 2017, from 8:30 a.m. to 2:30 p.m. ET. ADDRESSES: The meeting will be held at the 20 F Street NW. Conference Center, located at 20th F Street NW., Washington, DC 20001. To register to attend the meeting or deliver oral public testimony, please visit the Healthy People Web site at https:// www.healthypeople.gov. DATES: mstockstill on DSK30JT082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Rm. LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 453–8281 (fax). Additional information is available on the Healthy People Web site at https:// www.healthypeople.gov. SUPPLEMENTARY INFORMATION: Appointed Committee Members: The names and biographies of the appointed Committee members are available at https://www.healthypeople.gov/2020/ about/history-development/healthypeople-2030-advisory-committee. Purpose of Meeting: In accordance with Federal Advisory Committee Act and to promote transparency of the process, deliberations of the Committee will occur in a public forum. At this meeting, the Committee will continue its deliberations from the last public meeting. Background: The Committee, a federal advisory committee, is charged with issuing recommendations for the Secretary regarding the development and implementation of national health promotion and disease prevention objectives for 2030. The Committee will discuss the nation’s health promotion and disease prevention objectives and will provide recommendations to improve health status and reduce health risks for the nation by the year 2030. The Committee will develop recommendations regarding the criteria for identifying a more focused set of measurable, nationally representative objectives for improving the health of the nation by the year 2030 and recommendations for engaging VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 stakeholders in the implementation and achievement of the objectives. The Committee’s advice must assist the Secretary in reducing the number of objectives, while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data. Through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives that meet a broad range of health needs, encourage collaboration across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention and health promotion activities. Healthy People 2030 health objectives will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Meeting Agenda: The meeting agenda will include (a) opportunity for the public to give oral testimony, (b) review of Committee work since the last public meeting, and (c) plans for future Committee work. Public Participation at Meeting: Members of the public are invited to attend the Committee meeting. To attend the Committee meeting, individuals must pre-register at the Healthy People Web site at http:// www.healthypeople.gov. Registrations must be completed by 5:00 p.m. ET on September 1, 2017. Space for the meeting is limited and registration will be accepted until maximum room capacity is reached. A waiting list will be maintained should registrations exceed room capacity. Individuals on the waiting list will be contacted as additional space for the meeting becomes available. Registration questions may be directed to: Jim Nakayama at events@ nakamotogroup.com, or (240) 672–4011. Public Comments and Meeting Documents: An opportunity to present to the Committee oral comments regarding the proposed Healthy People 2030 vision, mission, overarching goals, foundational principles, and plan of action will be provided at this meeting. Those wishing to present oral comment must pre-register at the Healthy People Web site at www.healthypeople.gov by PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 5:00 p.m. ET, on August 21, 2017, and must submit a written copy of their oral testimony by 5:00 p.m. ET, on August 30, 2017, to Jim Nakayama at events@ nakamotogroup.com. The opportunity to deliver oral testimony is limited. Those presenting oral comments will have two (2) minutes to address the Committee. Guidelines for public comment submissions can be viewed at https://www.healthypeople.gov/2020/ About-Healthy-People/DevelopmentHealthy-People-2030/Public-Comment. Written public comments can be submitted and/or viewed at https:// www.healthypeople.gov/2020/AboutHealthy-People/Development-HealthyPeople-2030/Public-Comment/Items-forcomment. Documents pertaining to Committee deliberations, including meeting agendas and summaries are available at https:// www.healthypeople.gov/2020/AboutHealthy-People/Development-HealthyPeople-2030/Committee-Meetings. Questions regarding public comment may be directed to: Jim Nakayama at events@nakamotogroup.com or (240) 672–4011. Authority: 42 U.S.C. 217a. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: August 2, 2017. Don Wright, Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion). [FR Doc. 2017–16608 Filed 8–4–17; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Child Health and Human Development Council. The meeting will be open to the public as indicated below, with attendance limited to space available. A portion of this meeting will be closed to the public in accordance with the provisions set forth in sections E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 82, Number 150 (Monday, August 7, 2017)]
[Notices]
[Pages 36805-36806]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Announcement of Meeting of the Secretary's Advisory Committee on 
National Health Promotion and Disease Prevention Objectives for 2030

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Health and Human Services (HHS) 
announces the next meeting of the Secretary's Advisory Committee on 
National Health Promotion and Disease Prevention Objectives for 2030 
(Committee). The meeting is open to the public and will be held in the 
Washington, DC metropolitan area. The Committee is working to 
accomplish its mission to provide independent advice based on current 
scientific evidence for

[[Page 36806]]

use by the Secretary of the U.S. Department of Health and Human 
Services or a designated representative in the development of Healthy 
People 2030.

DATES: The Committee will meet on September 6, 2017, from 8:30 a.m. to 
5:00 p.m. Eastern Time (ET), and September 7, 2017, from 8:30 a.m. to 
2:30 p.m. ET.

ADDRESSES: The meeting will be held at the 20 F Street NW. Conference 
Center, located at 20th F Street NW., Washington, DC 20001. To register 
to attend the meeting or deliver oral public testimony, please visit 
the Healthy People Web site at https://www.healthypeople.gov.

FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal 
Officer, Secretary's Advisory Committee on National Health Promotion 
and Disease Prevention Objectives for 2030, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Rm. LL-100, Rockville, MD 20852, (240) 453-8280 (telephone), 
(240) 453-8281 (fax). Additional information is available on the 
Healthy People Web site at https://www.healthypeople.gov.

SUPPLEMENTARY INFORMATION: 
    Appointed Committee Members: The names and biographies of the 
appointed Committee members are available at https://www.healthypeople.gov/2020/about/history-development/healthy-people-2030-advisory-committee.
    Purpose of Meeting: In accordance with Federal Advisory Committee 
Act and to promote transparency of the process, deliberations of the 
Committee will occur in a public forum. At this meeting, the Committee 
will continue its deliberations from the last public meeting.
    Background: The Committee, a federal advisory committee, is charged 
with issuing recommendations for the Secretary regarding the 
development and implementation of national health promotion and disease 
prevention objectives for 2030. The Committee will discuss the nation's 
health promotion and disease prevention objectives and will provide 
recommendations to improve health status and reduce health risks for 
the nation by the year 2030. The Committee will develop recommendations 
regarding the criteria for identifying a more focused set of 
measurable, nationally representative objectives for improving the 
health of the nation by the year 2030 and recommendations for engaging 
stakeholders in the implementation and achievement of the objectives. 
The Committee's advice must assist the Secretary in reducing the number 
of objectives, while ensuring that the selection criteria identifies 
the most critical public health issues that are high-impact priorities 
supported by current national data. Through the Healthy People 
initiative, HHS leverages scientific insights and lessons from the past 
decade, along with new knowledge of current data, trends, and 
innovations, to develop the next iteration of national health promotion 
and disease prevention objectives. Healthy People provides science-
based, 10-year national objectives for promoting health and preventing 
disease. Since 1979, Healthy People has set and monitored national 
health objectives that meet a broad range of health needs, encourage 
collaboration across sectors, guide individuals toward making informed 
health decisions, and measure the impact of our prevention and health 
promotion activities. Healthy People 2030 health objectives will 
reflect assessments of major risks to health and wellness, changing 
public health priorities, and emerging technologies related to our 
nation's health preparedness and prevention.
    Meeting Agenda: The meeting agenda will include (a) opportunity for 
the public to give oral testimony, (b) review of Committee work since 
the last public meeting, and (c) plans for future Committee work.
    Public Participation at Meeting: Members of the public are invited 
to attend the Committee meeting. To attend the Committee meeting, 
individuals must pre-register at the Healthy People Web site at http://www.healthypeople.gov. Registrations must be completed by 5:00 p.m. ET 
on September 1, 2017. Space for the meeting is limited and registration 
will be accepted until maximum room capacity is reached. A waiting list 
will be maintained should registrations exceed room capacity. 
Individuals on the waiting list will be contacted as additional space 
for the meeting becomes available. Registration questions may be 
directed to: Jim Nakayama at events@nakamotogroup.com, or (240) 672-
4011.
    Public Comments and Meeting Documents: An opportunity to present to 
the Committee oral comments regarding the proposed Healthy People 2030 
vision, mission, overarching goals, foundational principles, and plan 
of action will be provided at this meeting. Those wishing to present 
oral comment must pre-register at the Healthy People Web site at 
www.healthypeople.gov by 5:00 p.m. ET, on August 21, 2017, and must 
submit a written copy of their oral testimony by 5:00 p.m. ET, on 
August 30, 2017, to Jim Nakayama at events@nakamotogroup.com. The 
opportunity to deliver oral testimony is limited. Those presenting oral 
comments will have two (2) minutes to address the Committee. Guidelines 
for public comment submissions can be viewed at https://www.healthypeople.gov/2020/About-Healthy-People/Development-Healthy-People-2030/Public-Comment. Written public comments can be submitted 
and/or viewed at https://www.healthypeople.gov/2020/About-Healthy-People/Development-Healthy-People-2030/Public-Comment/Items-for-comment. Documents pertaining to Committee deliberations, including 
meeting agendas and summaries are available at https://www.healthypeople.gov/2020/About-Healthy-People/Development-Healthy-People-2030/Committee-Meetings. Questions regarding public comment may 
be directed to: Jim Nakayama at events@nakamotogroup.com or (240) 672-
4011.
    Authority: 42 U.S.C. 217a. The Secretary's Advisory Committee on 
National Health Promotion and Disease Prevention Objectives for 2030 is 
governed by provisions of the Federal Advisory Committee Act (FACA), 
Public Law 92-463, as amended (5 U.S.C., App.) which sets forth 
standards for the formation and use of federal advisory committees.

    Dated: August 2, 2017.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health 
Promotion).
[FR Doc. 2017-16608 Filed 8-4-17; 8:45 am]
 BILLING CODE 4150-32-P